Showing 211-220 of 1349 results for "".
What's your Mobile Engagement Quotient?
https://practicaldermatology.com/topics/practice-management/meq/18486/Do you know your mobile engagement quotient? Do you even know what MEQ is? To connect with and expand your patient base, you need to enhance mobile engagement. Learn what you need to know in this Ekwa.com Marketing Educational video.Tailoring Your Consultations for Male Patients
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/tailoring-your-consultations-for-male-patients/18700/The injector must be familiar with strategies to achieve a satisfactory outcome. It's important to understand the male facial anatomy and know what features are desirable. Terrence Keaney, MD, explains.The Male Aesthetic Patient: Who He Is and What He Needs
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/the-male-aesthetic-patient-who-he-is-and-what-he-needs/18701/Baby boomer men aren't necessarily driving the growth in male aesthetics. Terrence Keaney, MD says that millennial men in their 30s and 40s are most likely to seek treatments. In the initial consultation, education is essential so men understand the treatments offered and recognize that you understaTo Be Shorr: Negotiate with Confidence
https://practicaldermatology.com/topics/practice-management/to-be-shorr-negotiate-with-confidence/18717/Knowing when and how to negotiate is key. Sometimes, the best outcome is possible when a third party negotiates on your behalf. Jay Shorr explains in this edition of To Be Shorr.Advances in Treating NMSC
https://practicaldermatology.com/topics/skin-cancer-photoprotection/advances-in-treating-nmsc/18742/Dr. Goldenberg discusses the benefits of timed sequential therapy using two modalities — destructive therapy followed by field therapy — for actinic keratoses. He also talks about treatment options for advanced basal cell carcinoma, squamous cell carcinoma, and merkel cell carcinoma.Device Delegation: Don't Get Burned
https://practicaldermatology.com/topics/practice-management/device-delegation-dont-get-burned/21015/Know the ins and outs of device delegation to avoid unwanted outcomes.Driving Growth in the Dermatology Practice
https://practicaldermatology.com/topics/practice-management/driving-growth-in-the-dermatology-practice/18630/Robert Rullo reminds dermatologists to think beyond being just a clinician and to remember they are also running a business. He discusses key business philosophies clinicians need to be aware of and common obstacles that inhibit geometric practice growth. GenerationsSeborrheic Dermatitis Update: A Review of the Etiology and Treatment of Seborrheic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology/seborrheic-dermatitis-update-a-review-of-the-etiology-and-treatment-of-seborrheic-dermatitis/24003/Seborrheic dermatitis (SD) is an inflammatory skin condition that often involves flaky, erythematous patches on sebum-rich areas of the body such as the face and scalp.1 At least 50 million Americans have a form of seborrheic dermatitis on the scalp, more commonly known as dandruff. SD presents in aThe State of Private Equity in 2024: Impact on the Practice of Dermatology
https://practicaldermatology.com/columns/practice-management/state-private-equity-2024-impact-practice-dermatology/27173/Physician Growth Partners recently published a white paper, “State of Dermatology Private Equity,” that evaluated market trends, strategies, and more. Practical Dermatology® spoke exclusively with CEO Michael Kroin about how the evolution of private equity is impacting the everyday practitioner andAdvantages of More Topical Gel
https://practicaldermatology.com/programs/practical-dermatology/advantages-of-more-topical-gel/29176/Dr. Ashish Bhatia discusses increased dosing of a PDT photosensitizer for both lesion-directed and field-directed treatment of actinic keratosis.